Attempt 112 - Assort Design

Attempt #112

Job: 85 • Audience: medical_affairs • Passed: True • Created: 2026-03-15 20:43:50.994787

Back to Request View Source Back Home

Routing Reasons

The document discusses clinical trial results on multivitamin effects on biological aging using epigenetic biomarkers, indicating a focus on clinical evidence.; It references expert opinions from medical doctors and researchers, showing relevance to medical professionals.; The content includes details on study design, epigenetic clocks, and ongoing research needs, which are typical concerns of medical affairs teams communicating scientific findings to healthcare stakeholders.; While it is accessible to general audiences, the scientific depth and focus on clinical trials and implications for health advice align more with medical affairs than purely commercial or R&D audiences.

One-line Summary

A large randomized clinical trial (COSMOS) suggests that daily multivitamin use modestly slows biological aging in older adults, especially those with accelerated aging, though further research is needed.

Decision Bullets

Scientific Summary: Daily multivitamin use correlates with slowed biological aging measured by select epigenetic clocks in older adults.
Evidence Gaps: Unclear if slowed epigenetic aging translates to reduced clinical outcomes; mechanism and key ingredients unknown; lack of diverse population data.
Medical Insights: Multivitamins may benefit those with accelerated biological aging; dietary intake remains primary recommendation; supplement quality critical.
Stakeholder Considerations: Patients seek accessible interventions; clinicians require robust long-term data before firm recommendations; supplement industry impact.
Next Steps: Conduct long-term trials assessing clinical endpoints, replicate findings in diverse cohorts, investigate mechanism, and compare with lifestyle interventions.

Key Clues

COSMOS trial: 958 older adults, avg. age 70, multivitamin vs placebo
Multivitamin slowed PCGrimAge and PCPhenoAge epigenetic clocks by 2.7–5.1 months over 2 years
Greater benefit in participants biologically older than chronological age
No significant effect on Horvath, Hannum clocks or DunedinPACE
Multivitamin contains essential vitamins and minerals in standard Centrum Silver formulation

Mind Map (Raw)

mindmap
  root((Biological Aging & Multivitamin))
    Trial(COSMOS Trial)
      Participants(Older Adults, avg age 70)
      Intervention(Daily Multivitamin)
      Control(Placebo)
      Duration(2 Years)
    Outcomes
      Epigenetic Clocks
        Slowed(PCGrimAge, PCPhenoAge)
        No Change(Horvath, Hannum, DunedinPACE)
      Aging Effect(Slowing by 2.7-5.1 months)
      Subgroup(Benefit in Biologically Older Participants)
    Insights
      Supplement(Contain A, C, D3, E, K, B vitamins, minerals)
      Limitations(Lack of clinical outcome data, unknown mechanism)
    Recommendations
      Diet(Food first, supplements second)
      Quality(Third-party tested supplements)
    NextSteps
      Research(Long-term outcomes, diverse populations)
      Mechanism(Identify active ingredients)
      Comparison(With lifestyle approaches)

Evaluator Verdict

{
  "fail_reasons": [],
  "fix_instructions": [],
  "missing_sections": [],
  "pass": true,
  "support_warning": false,
  "word_count": 177
}

Raw JSON

These are the JSON payloads stored per attempt.

{
  "decision_bullets": [
    "Scientific Summary: Daily multivitamin use correlates with slowed biological aging measured by select epigenetic clocks in older adults.",
    "Evidence Gaps: Unclear if slowed epigenetic aging translates to reduced clinical outcomes; mechanism and key ingredients unknown; lack of diverse population data.",
    "Medical Insights: Multivitamins may benefit those with accelerated biological aging; dietary intake remains primary recommendation; supplement quality critical.",
    "Stakeholder Considerations: Patients seek accessible interventions; clinicians require robust long-term data before firm recommendations; supplement industry impact.",
    "Next Steps: Conduct long-term trials assessing clinical endpoints, replicate findings in diverse cohorts, investigate mechanism, and compare with lifestyle interventions."
  ],
  "evaluator": {
    "fail_reasons": [],
    "fix_instructions": [],
    "missing_sections": [],
    "pass": true,
    "support_warning": false,
    "word_count": 177
  },
  "key_clues": [
    "COSMOS trial: 958 older adults, avg. age 70, multivitamin vs placebo",
    "Multivitamin slowed PCGrimAge and PCPhenoAge epigenetic clocks by 2.7\u20135.1 months over 2 years",
    "Greater benefit in participants biologically older than chronological age",
    "No significant effect on Horvath, Hannum clocks or DunedinPACE",
    "Multivitamin contains essential vitamins and minerals in standard Centrum Silver formulation"
  ],
  "tags": [
    "biological aging",
    "multivitamin",
    "epigenetic clocks",
    "clinical trial",
    "older adults",
    "nutrition",
    "healthy aging"
  ]
}